US Stock MarketDetailed Quotes

DVAX Dynavax Technologies

Watchlist
  • 14.400
  • +0.060+0.42%
Close Mar 7 16:00 ET
  • 14.580
  • +0.180+1.25%
Post 20:01 ET
1.79BMarket Cap72.00P/E (TTM)

About Dynavax Technologies Company

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Company Profile

SymbolDVAX
Company NameDynavax Technologies
Listing DateFeb 19, 2004
Issue Price7.50
Founded1996
CEOMr. Ryan Spencer
MarketNASDAQ
Employees405
Fiscal Year Ends12-31
Address2100 Powell Street,Suite 720
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-848-5100
Websitehttp://www.dynavax.com

Company Executives

  • Name
  • Position
  • Salary
  • Ryan Spencer
  • Chief Executive Officer and Director
  • --
  • Kelly MacDonald
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Robert Janssen, M.D.
  • Chief Medical Officer and Senior Vice President, Clinical Development, Medical and Regulatory Affairs
  • --
  • David Novack
  • President and Chief Operating Officer
  • --
  • John L. Slebir
  • Senior Vice President and General Counsel
  • --
  • Scott D. Myers
  • Chairman of the Board
  • 323.73K
  • Lauren P. Silvernail
  • Director
  • --
  • Dr. Emilio Emini
  • Director
  • --
  • Julie M. Eastland
  • Independent Director
  • 293.73K
  • Dr. Francis R. Cano, PhD
  • Independent Director
  • 278.73K
  • Dr. Peter R. Paradiso, PhD
  • Independent Director
  • 277.73K
  • Peggy V. Phillips
  • Independent Director
  • 298.73K
  • Brent MacGregor
  • Independent Director
  • 278.73K
  • Dr. Daniel L. Kisner, M.D.
  • Independent Director
  • 290.73K
  • Elaine D. Sun
  • Independent Director
  • 278.73K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
NEW WELLLINK
871634
+30.00%
VIBO
871245
+29.99%
MTD
835579
+29.98%
4
REFORMER
833030
+29.98%
5
Hunan Sundy Science And Technology
300515
+20.02%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!